1. Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
- Author
-
Louis, Edouard, primary, Resche-Rigon, Matthieu, additional, Laharie, David, additional, Satsangi, Jack, additional, Ding, Nik, additional, Siegmund, Britta, additional, D'Haens, Geert, additional, Picon, Laurence, additional, Bossuyt, Peter, additional, Vuitton, Lucine, additional, Irving, Peter, additional, Viennot, Stephanie, additional, Lamb, Christopher A, additional, Pollok, Richard, additional, Baert, Filip, additional, Nachury, Maria, additional, Fumery, Mathurin, additional, Gilletta, Cyrielle, additional, Almer, Sven, additional, Ben-Horin, Shomron, additional, Bouhnik, Yoram, additional, Colombel, Jean-Frederic, additional, Hertervig, Erik, additional, Andrews, Jane, additional, Sparrow, Miles, additional, Leong, Rupert, additional, Connor, Susan, additional, Radforth-Smith, Graham, additional, De Cruz, Peter, additional, Preiss, Jan, additional, Stallmach, Andrea, additional, Liceni, Thomas, additional, Grip, Olaf, additional, Halfvarson, Jonas, additional, Durai, Dharmaraj, additional, Cummings, Fraser, additional, Seilinger, Christian, additional, Parkes, Miles, additional, Lindsay, James, additional, Lambrecht, Guy, additional, Van Hootegem, Philippe, additional, Rahier, Jean-François, additional, Dewitte, Marie, additional, Hebuterne, Xavier, additional, Chanteloup, Elise, additional, Altwegg, Romain, additional, Nancey, Stephane, additional, Bouguen, Guillaume, additional, Pineton de Chambrun, Guillaume, additional, Poullenot, Floriant, additional, and Roblin, Xavier, additional
- Published
- 2023
- Full Text
- View/download PDF